Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4

1(50.0%)

N/A

1(50.0%)

2Total

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07575880Not Yet Recruiting

Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care Pathway

Role: lead

NCT07524036Not ApplicableNot Yet Recruiting

Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan.

Role: collaborator

NCT07277361Recruiting

Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment

Role: collaborator

NCT07090460Recruiting

Pulmonary Overdistension Assessment With Electrical Impedance Tomography in Patients With Acute Respiratory Distress Syndrom in Prone Position.

Role: lead

NCT04517448Terminated

Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy

Role: lead

NCT02847507Completed

Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)

Role: lead

NCT03004651Completed

BMI and Ultrasound/Clinical Assessments of RA Disease Activity

Role: collaborator

NCT01765257Phase 4Unknown

Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study

Role: collaborator

All 8 trials loaded